NSDL, India’s largest depository, is launching a ₹3,000 crore IPO in March, entirely as an offer for sale. Key banking stocks ...
1h
Hosted on MSNAzad Engineering launches Rs 700 crore QIP: All you need to knowThe company's board approved the opening of the issue on February 25 for the QIP of equity shares with a face value of Rs 2 ...
Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
11h
Hosted on MSNHow To Invest in the ThoughtSpot IPO: A Beginner’s GuideInvesting in ThoughtSpot’s IPO might be a good move to add to your portfolio, It has beating out competitors other analytics ...
Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.
Basel Medical Group (NASDAQ:BMGL) shares were up 4% in late afternoon trading Tuesday following a $9M U.S. initial public ...
Hosted on MSN16h
Krispy Kreme (DNUT) Stock Trades Down, Here Is WhyWhat Happened? Shares of doughnut chain Krispy Kreme (NASDAQ:DNUT) fell 26.1% in the pre-market session after the company ...
16h
Investor's Business Daily on MSNHow To Invest: Rules For When To Buy And Sell Stocks In Bull And Bear MarketsIn bull and bear markets, investors need rules to stay both profitable and protected. Here are seven lessons to get started.
A brief history of Netflix stock. Netflix was founded in 1997 as a competitor to Blockbuster, operating a DVD-by-mail rental ...
Nearly half of the new-age companies listed since 2021 are trading below their IPO price. This and more in today’s ETtech Top ...
Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...
Paytm, Delhivery, and Honasa are the top losers, while Zomato and PB Fintech have stood up successfully against the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results